Ultra-processed foods lacking fiber and protein leave you hungry despite high calories
Combining glucagon-receptor agonism with GLP-1/GIP agonism would seem to work against itself
Josiah Allen, PharmD, has spent over 15 years in the field of pharmacogenomics, beginning at the Mayo Clinic where he helped develop the GeneSight test
Semaglutide (known by brand names like Ozempic and Wegovy) is a GLP-1 receptor agonist that mimics the body's natural GLP-1 hormone to reduce appetite, slow gastric emptying, and create a prolonged feeling of fullness
Semaglutide's 1522% weight reduction in clinical trials far exceeds Lipo C's documented effects, making it the more evidence-backed starting point
In adults, it lowered total daily insulin needs by 0.44 units per kg